Zobrazeno 1 - 4
of 4
pro vyhledávání: '"therapy and lamivudine"'
Publikováno v:
Annals of Hepatology, Vol 10, Iss 2, Pp 165-173 (2011)
Objectives. To assess the efficacy of anti-viral therapy on hepatitis B virus associated glomerulonephritis (HBV-GN).Design, setting, participants, & measurements. We searched PubMed, Embase and Cochrane Library for prospective controlled trials whic
Externí odkaz:
https://doaj.org/article/8bfff94a896a4961aca26dd199e127c2
Autor:
Upadhyay Dip Amal, Radhakrishnan Sivasankara, Dhar Anjan, Khashoub Masoud, Al Busaidi Sulaiman, Mohan Akkanapragada, Al Zubaidi Ghazi Bin Omer
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 9, Iss 2, Pp 69-74 (2003)
Background: Chronic hepatitis B (CHB) in Oman is similar to the Mediterranean Region with significant number of HBeAg negative patients. Interferon therapy is less effective in these patients and lamivudine is an alternative treatment. Patients and M
Externí odkaz:
https://doaj.org/article/7fd059ecf6814f01b582d862e8c49b79
Autor:
H Chappuy, Serge Diagbouga, Joëlle Nicolas, Msellati P, Aly Drabo, Hervé Hien, Nicolas Meda, Jerôme Somé, Souleymane Yameogo, Adama Ouiminga, Alain Hien, François Rouet, Hassane Tamboura, Emmanuelle Zoure, P Van de Perre, Boubacar Nacro
Publikováno v:
African Health Sciences; Vol 13, No 2 (2013); 287-294
Background: There is no data on long-term benefit of once-a-day antiretroviral therapy (ART) with combination of DDI, 3TC and EFV to allow its use in future therapeutic strategies.Objectives: To assess 24-month immuno-virological, adherence, toleranc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d963b233087331c897f89e03f1b265e
https://europepmc.org/articles/PMC3824505/
https://europepmc.org/articles/PMC3824505/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.